News

Goldman Sachs Predicts S&P 500 could Surpass 6,000 in 2024

Goldman Sachs Predicts S&P 500 could Surpass 6,000 in 2024

Goldman Sachs Anticipates Major S&P 500 Growth

The S&P 500 index has made headlines with its impressive ascent, recently achieving 46 new all-time highs in 2024. It has experienced a significant increase of 42.3% from its low recorded on October 27, 2023, marking it as one of the most extraordinary 12-month rallies ever.

Market Expectations for 2024

As we prepare to close the year, the S&P 500 indicates no intention of slowing down. With 54 trading days left in the year, analysts and market strategists project a robust finish. The outlook for 2024 has been particularly positive, leading to heightened speculation regarding the index's positioning.

Strategist Insights on S&P 500 Projections

In a recent assessment, analysts from UBS have raised their targets for the S&P 500 for both 2024 and 2025, encouraging a more positive sentiment among traders. Additionally, strategists at Goldman Sachs have identified a noticeable shift in their clients' investment practices, moving from defensive hedging strategies to more aggressive positions in anticipation of a year-end rally.

Fear of Missing Out Drives Investment

The shift in strategy among institutional investors stems primarily from a fear of lagging behind equity benchmarks, often referred to as "FOMU" — the fear of missing out. This behavioral shift has led to predictions that the S&P 500 could exceed 6,000 by the year’s end.

Critical Earnings Reports Ahead

The upcoming week in the market is set to be pivotal, with 37% of S&P 500 companies preparing to release their quarterly earnings. These reports could significantly impact market movements and investor sentiment as the year draws to a close.

Corporate Buying Spree Expected

Moreover, with the end of the blackout period for U.S. companies on October 25th, strategists expect large corporations to become the major players in the equity market this year. Analysts forecast that these firms might add around $6 billion into the market each day until the end of 2024.

Shifting Market Dynamics

This influx of corporate buying activity coincides with the phasing out of significant market sellers as we approach Halloween. Additionally, the mutual fund year-end on October 31st is likely to play a crucial role, with around $1.85 trillion in assets being reported across nearly 800 mutual funds.

Household Investment Trends

Historically, household investments in equities tend to climb in November, particularly in the wake of election years. Goldman Sachs has noted that the median return for the S&P 500 from mid-October to the end of December is +5.17% since 1928. If current trends hold, a year-end level of approximately 6,160 could be realistic based on present performance.

Election Year Patterns Favor Positive Returns

Interestingly, during election years, this median return tends to increase to around +7%, suggesting a potential year-end level of 6,270. This pattern is not isolated to the S&P 500; it is evident in other indices as well. For instance, the Nasdaq 100 and the US Small Cap 2000 are also expected to display robust performances, potentially reaching 22,900 and 2,425, respectively, by year-end.

Frequently Asked Questions

What are the current predictions for the S&P 500?

Analysts predict that the S&P 500 could exceed 6,000 by year-end 2024, driven by strong corporate buying and strategic shifts in investment approaches.

How much are U.S. corporates expected to invest in the market?

U.S. corporations are expected to inject around $6 billion daily into the stock market until the end of the year.

Why are institutional investors changing their strategies?

Investors are shifting from defensive strategies to more aggressive ones due to a fear of underperforming against benchmark equity indices.

What is the historical trend for the S&P 500 during election years?

Historically, the median return for the S&P 500 between mid-October and December has increased significantly during election years.

What impact do quarterly earnings reports have on stock prices?

Quarterly earnings reports, especially from a large percentage of S&P 500 companies, can significantly influence market sentiment and stock prices.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 99

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 211

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 138

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

CNX Resources Reveals Third Quarter Results and Upcoming Call

Updated Category News Views 36

CNX Resources Corporation Financial Update CNX Resources Corporation (NYSE: CNX) is gearing up to announce its financial outcomes for the third quarter of 2024. This announcement is scheduled for 6:45 a.m. Eastern Time on a Thursday morning toward the end of October. During this time, CNX will also share essential materials, including remarks prepared for the quarter,...

Continue Reading
MBZUAI Enhances Research Collaboration with École Polytechnique

Updated Category News Views 183

Strengthening Research Cooperation Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has officially expanded its strategic partnership with École Polytechnique, aiming for a more profound collaboration in artificial intelligence (AI) research. This new Collaborative Research Agreement is a significant step towards enhancing research capabilities in both...

Continue Reading
Projected Growth of Marine Collagen: Key Insights and Trends

Updated Category News Views 152

The Growing Marine Collagen Market The marine collagen market is set to experience significant growth in the coming years. As consumer awareness around health and beauty continues to rise, we see a shift in preference towards marine collagen, thanks to its impressive bioavailability and sustainable sourcing methods. Recent analyses reveal that this sector is predicted to...

Continue Reading
BioLife Solutions Prepares for Q1 2025 Financial Disclosure

Updated Category News Views 144

Exciting Financial Insights Awaiting from BioLife Solutions BioLife Solutions, Inc. (NASDAQ: BLFS) has announced that it will disclose its first quarter 2025 financial results, marking an important update for investors and stakeholders alike. This revelation is set to occur after the market closes, creating anticipation among those closely monitoring the company’s...

Continue Reading
FuboTV Achieves Record Subscriber Growth in North America

Updated Category News Views 174

FuboTV Reports Unprecedented Subscriber Growth FuboTV (NYSE: FUBO) has recently made headlines as it recorded the highest-ever growth in its North American subscriber base. This achievement highlights the company’s potential in the competitive streaming industry. The stock saw a notable increase on the day the company announced its earnings for the third quarter....

Continue Reading